Jump to content [AK + s] Jump to navigation [AK + 3]

Annual Report 2014

English | Dutch
  • Twitter
  • LinkedIn

Primary Menu

  • The Galapagos Group
    • Letter from the CEO
    • At a glance
    • Strategy
    • Overview of Galapagos NV
    • Going concern statement
    • Risk management
    • The Galapagos share
    • Subsequent events
    • Disclaimer and other information
  • R&D
    • The Galapagos pipeline
    • Target discovery
    • Rheumatoid arthritis
    • Inflammatory bowel disease
    • Cystic fibrosis
    • IPF
  • Risk factors
    • Financial position and need for additional capital
    • Product development, regulatory approval and commercialization
    • Reliance on third parties
    • Competitive position
    • Intellectual property
    • Organization, structure and operation
    • Galapagos shares
    • General statement
  • Corporate governance
    • Policies
    • Board of Directors
    • Committees
    • Share capital and shares
    • Shareholders
    • Remuneration report
      • Determination
      • Policy
      • Non-executive Directors
      • Executive Directors
      • Criteria and methods to evaluate performance
      • Gross remuneration of CEO
      • Gross remuneration of other Executive Committee members
      • Shares, warrants or other rights
      • Contractual provisions
      • Severance payments
      • Claw-back right
    • Conflict of interests and related parties
    • Statement by the Board of Directors
  • Financial statements
    • Consolidated financial statements
      • Income statement and statement of comprehensive income
      • Statements of financial position
      • Cash flow statements
      • Statements of changes in equity
    • Non-consolidated financial statements
  • Notes
    • Notes to the consolidated financial statements
      • Notes 1-10
        • 1. General Information
        • 2. Significant accounting policies
        • 3. Segment information
        • 4. Total revenues and other income
        • 5. Operating costs
        • 6. Staff costs
        • 7. Finance income and expense
        • 8. Taxes
        • 9. Discontinued operations
        • 10. Result per share
      • Notes 11-20
        • 11. Goodwill
        • 12. Intangible assets
        • 13. Property, plant and equipment
        • 14. Research and Development incentives receivables
        • 15. Other non-currrent assets
        • 16. Restricted cash
        • 17. Inventory
        • 18. Trade and other receivables and other current assets
        • 19. Cash and cash equivalents
        • 20. Share capital
      • Notes 21-30
        • 21. Share premium
        • 22. Other reserves
        • 23. Translation differences
        • 24. Deferred tax
        • 25. Finance lease liabilities
        • 26. Trade and other payables
        • 27. Provisions
        • 28. Operating lease obligations
        • 29. Off-balance sheet arrangements
        • 30. Contingent assets and liabilities
      • Notes 31-40
        • 31. Retirement benefit plans
        • 32. Warrant plans
        • 33. Related parties
        • 34. Remuneration of key management personnel
        • 35. Consolidated companies as of 31 December 2014
        • 36. Company acquistions and disposals
        • 37. Critical accounting estimates and judgments
        • 38. Financial risk management
        • 39. Auditor’s remuneration
        • 40. Events after balance sheet date
    • Report of the statutory auditor

Notes

  • Notes to the consolidated financial statements
    • Notes 1-10
    • Notes 11-20
      • 11. Goodwill
      • 12. Intangible assets
      • 13. Property, plant and equipment
      • 14. Research and Development incentives receivables
      • 15. Other non-currrent assets
      • 16. Restricted cash
      • 17. Inventory
      • 18. Trade and other receivables and other current assets
      • 19. Cash and cash equivalents
      • 20. Share capital
    • Notes 21-30
    • Notes 31-40
  • Report of the statutory auditor

You are here:

  • Home
  • NotesNotes to the consolidated financial statementsNotes 11-20
  • 17. Inventory
  • Notes 11-20
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
17. Inventory

17. Inventory

(XLS:) Download XLS

 

Year ended 31 December,

(thousands of €)

2014

2013

Raw materials and supplies (net)

281

249

Total inventory

281

249

Inventory only consists of raw materials and supplies.

previous pagenext page
Download Center
to page top

Service

  • Glossary of terms
  • Downloads
  • Financial calendar
  • Galapagos Corporate Website

Last Update 26 March 2015

Galapagos Annual Report 2014 (PDF)

Download the entire report as PDF.

Download PDF (8 MB)
  • © Copyright 2015 Galapagos NV
  • Colophon
  • Contact
  • Sitemap
nexxar - digital reporting evolved - Online Report